Penile Cancer Treatment in Hyderabad — Expert Surgical Oncology Care Across 7 Locations
A penile cancer diagnosis comes with fears that go beyond the cancer itself. For most men diagnosed at an early stage, organ-sparing treatment — surgery that removes the cancer while preserving the penis — is the recommended approach. CION's surgical and radiation oncology team manages the full range of options, backed by NABH accreditation and NCCN protocols.
- Organ-sparing surgery first — evaluated for every eligible patient before penectomy is recommended
- Sentinel lymph node biopsy — minimally invasive groin assessment that avoids the lymphoedema risk of full dissection
- IMRT precision radiation — primary organ-preserving option for selected cases, or adjuvant after surgery
- Same-week confidential consultation — across 7 Hyderabad locations · NABH accredited
on Panel
Survival Rate*
Treated
(800+ reviews)
Did You Know?
For men with early-stage penile cancer confined to the surface of the glans (head of the penis) or foreskin, organ-sparing surgery can remove the cancer completely while preserving penile appearance and function. Total penectomy — removal of the entire penis — is reserved for advanced disease involving the deeper penile tissue and is far less commonly required than most patients fear. Early diagnosis makes organ-sparing approaches possible in the majority of cases.
What Is Penile Cancer?
Penile cancer develops when cells in the skin or tissues of the penis start to grow abnormally. Most penile cancers — about 95% — are squamous cell carcinomas, a type of cancer that begins in the flat cells covering the outer surface of the skin. They most commonly arise on the foreskin (the fold of skin covering the head of the penis in uncircumcised men) or on the glans — the head of the penis.
Penile cancer is rare globally, but India has a meaningfully higher incidence than Western countries. This is linked to a higher prevalence of phimosis (a condition where the foreskin cannot be fully pulled back) and the associated hygiene challenges, as well as HPV infection rates. Early detection gives excellent outcomes — penile cancer found at Stage I has cure rates exceeding 85%.
Risk Factors for Penile Cancer
Most penile cancers are linked to a small set of identifiable risk factors. Knowing these makes earlier detection — and prevention — possible.
HPV Infection
Certain types of HPV are found in approximately 40 to 50% of penile cancer cases. HPV vaccination in young men reduces risk significantly.
Phimosis
A condition where the foreskin cannot be fully retracted. This allows smegma to accumulate under the foreskin, creating a chronic inflammatory environment — a significant risk factor particularly relevant in India.
Poor Penile Hygiene
Insufficient cleaning under the foreskin over many years, especially in uncircumcised men, sustains chronic inflammation that can progress to cancer.
Smoking
Tobacco use is associated with significantly increased risk of penile cancer. Cessation reduces overall lifetime risk.
Weakened Immune System
Men with HIV infection or those taking medicines that suppress the immune system (transplant patients, autoimmune conditions) have a higher risk.
Age Over 50
Penile cancer is most common in men over 50, though it can occur at any age. Lifetime risk rises gradually with age.
Lichen Sclerosus
A chronic skin condition (balanitis xerotica obliterans) affecting the penis. It can progress to cancer if untreated — making early dermatological review important.
Circumcision in infancy or early childhood significantly reduces lifetime risk by eliminating the conditions associated with phimosis and smegma accumulation. Circumcision in adulthood does not eliminate risk, particularly if HPV exposure has already occurred.
Symptoms of Penile Cancer — When to Seek Help
Penile cancer is one of the most underreported cancers in men, partly because of embarrassment and partly because early symptoms are easy to attribute to skin infections or other common conditions. Any change on the penis that does not resolve within 4 weeks should be assessed by a doctor.
- A sore, ulcer, or non-healing lesion on the penis — the most common presentation; may appear on the glans or foreskin; does not heal despite ordinary wound care or antibiotic cream
- A lump, thickening, or raised area on the penis or foreskin
- Changes in the colour or texture of the skin — reddening, whitening, or a rough, warty appearance
- Unusual discharge from under the foreskin, or a persistent unpleasant odour despite good hygiene
- Bleeding from the penis or under the foreskin not caused by injury
- Swollen lumps in the groin — enlarged lymph nodes that persist for several weeks may indicate cancer has spread to these nodes
Many of these symptoms have benign causes — genital warts, skin conditions, or infection — but only a clinical examination and biopsy can confirm the diagnosis. Do not wait for the symptom to become painful; penile cancer is often painless in its early stages. Speak to a CION surgical oncologist — all consultations are handled with complete confidentiality.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Talk to a Penile Cancer Specialist Today
All consultations are handled with complete confidentiality. Same-week appointments across 7 Hyderabad locations.
How Is Penile Cancer Diagnosed at CION?
Confirming penile cancer requires three things: histological proof from a biopsy, accurate measurement of how deep the tumour has invaded, and assessment of whether the groin lymph nodes are involved. CION's diagnostic pathway covers all three before any treatment decision is made.
Biopsy — the Only Definitive Test
A small piece of tissue is taken from the lesion under local anaesthetic and examined under a microscope. The biopsy confirms whether the abnormality is cancer, and determines the cancer type and grade. The result drives the entire treatment pathway. In most cases, a biopsy can be performed in an outpatient setting.
MRI of the Penis
MRI provides the most detailed imaging of the penis, showing how deeply the tumour has invaded into the penile tissue and whether it has reached the underlying erectile tissue. This information is critical for deciding whether organ-sparing surgery is feasible. MRI is performed with the penis in a slightly stretched position using a specialist protocol.
Groin and Pelvic Assessment
Ultrasound of the groin checks whether the lymph nodes there are enlarged and suspicious. A CT scan of chest, abdomen, and pelvis assesses pelvic nodes and checks for distant spread. If groin nodes are enlarged, a fine needle aspiration (FNA) under ultrasound guidance confirms whether they contain cancer cells.
Penile Cancer Staging and Treatment by Stage
Penile cancer is staged using the AJCC TNM system, based on how deeply the tumour has grown into the penile tissue and whether the groin lymph nodes are involved. Stage at diagnosis is the most important factor in determining whether organ-sparing surgery is possible.
| Stage | Tumour Depth | Lymph Node Status | 5-Year Survival | Primary Treatment |
|---|---|---|---|---|
| Stage 0 (Tis/Ta) | Surface only — no invasion | No node involvement | 95–100% | Wide local excision, laser therapy, topical treatment, or circumcision |
| Stage I | Into superficial tissue (dermis); low grade | No node involvement | 85–95% | Wide local excision or glansectomy (organ-sparing) |
| Stage II | Into erectile tissue or urethra, or high-grade T1 | No node involvement | 70–85% | Partial penectomy or glansectomy; sentinel node biopsy |
| Stage IIIa | Any depth | 1–2 groin nodes involved | 50–70% | Partial/total penectomy + inguinal lymph node dissection |
| Stage IIIb | Any depth | 3+ groin nodes or bilateral | 30–50% | Surgery + chemotherapy ± radiation |
| Stage IV | Invades adjacent structures or distant spread | Pelvic nodes or distant metastases | 10–30% | Chemotherapy ± radiation; surgery for local control |
Survival figures reflect NCCN-grade specialist care and are influenced by individual patient factors. The table reflects standard AJCC TNM recommendations and is subject to tumour board review for every case.
Can Penile Cancer Be Treated Without Removing the Penis?
For most men with early-stage penile cancer — Stages 0, I, and selected Stage II — the answer is yes. Organ-sparing surgery is the internationally recommended first-line approach for eligible patients, and the goal of every surgical plan at CION is to remove the cancer completely while preserving as much of the penis as possible.
Wide Local Excision
The simplest organ-sparing procedure: the tumour is surgically removed with a clear margin of surrounding healthy tissue. Suitable for small, well-defined tumours on the shaft or foreskin. The remaining skin is closed directly. Most patients retain normal appearance and function.
Glansectomy with Skin Graft Reconstruction
For tumours involving the glans, the head of the penis is removed and the exposed end is resurfaced with a thin skin graft (usually from the inner thigh or groin). Maintains the ability to urinate normally and, in most cases, preserves sexual sensation over time. Equivalent cancer control to partial penectomy with significantly better quality-of-life outcomes.
Laser Ablation
For Stage 0 or very early Stage I lesions limited to the skin surface without deep invasion, laser ablation can destroy the cancer cells precisely without cutting. Multiple sessions may be needed. Regular follow-up biopsies confirm complete clearance. Preserves the full penis and normal function.
Circumcision
For cancers strictly confined to the foreskin, circumcision — surgical removal of the foreskin — may be the complete treatment. Applies to a subset of penile cancers; requires biopsy confirmation that the cancer has not extended beyond the foreskin.
If a partial or total penectomy has been recommended for your cancer, and you have not yet had a specialist surgical oncology review to assess whether organ-sparing surgery is an option, CION's dedicated Second Opinion service can evaluate this.
Treatment for More Advanced Penile Cancer
When the tumour has invaded deeper into the penile tissue, more extensive surgery may be required. Both procedures are followed by full pre- and post-operative psychological support.
Partial Penectomy
Removes the affected portion of the penis when the tumour has invaded the erectile tissue, or when organ-sparing surgery cannot achieve a clear margin. The remaining penile stump is sufficient for the patient to urinate standing up and, in many cases, to remain sexually active. Reconstruction of the urethral opening is performed at the same operation. Achieves excellent local tumour control.
Total Penectomy with Urinary Diversion
Removal of the entire penis — required for tumours extending to the base or involving most of the shaft. A new urinary opening is created in the perineum so the patient can urinate normally while seated. The most psychologically challenging outcome of penile cancer treatment; CION provides full pre-operative counselling and post-operative psychological support. For selected patients, penile reconstruction can be discussed with a plastic surgery partner.
Managing the Groin Lymph Nodes — Sentinel Biopsy vs Full Dissection
Penile cancer tends to spread first to the lymph nodes in the groin before reaching distant organs. Managing these nodes correctly is one of the most important aspects of penile cancer surgery — and it carries its own risks.
Full removal of all groin lymph nodes on one or both sides (inguinal lymphadenectomy) is a significant operation that — while effective — carries a meaningful risk of lymphoedema: severe, long-term swelling of the leg caused by disruption of the lymphatic drainage system. For patients whose groin nodes are not clearly involved on imaging, a less invasive approach — sentinel node biopsy — is now recommended at specialist centres.
Sentinel Lymph Node Biopsy
A minimally invasive technique that identifies and samples only the first lymph node (or nodes) that drain from the tumour — the sentinel nodes. A radioactive tracer is injected near the tumour before the operation; the tracer travels to the first draining nodes, which are then identified with a detector and removed for analysis. If the sentinel nodes are cancer-free, the remaining groin nodes are very unlikely to be involved and a full dissection is avoided. If the sentinel nodes contain cancer, a complete groin dissection is performed.
Sentinel node biopsy significantly reduces the risk of lymphoedema in patients with early-stage penile cancer while still ensuring that any involved nodes are detected. CION's surgical oncology team evaluates every eligible patient for sentinel node biopsy as part of standard treatment planning.
Radiation Therapy for Penile Cancer
Radiation therapy plays a specific role in penile cancer management:
- Primary organ-preserving treatment — for selected patients with small, early-stage tumours who cannot undergo or decline surgery; external beam radiation can control the cancer while preserving the penis; requires close follow-up as local recurrence rates are higher than with surgery
- After surgery (adjuvant) — to reduce the risk of the cancer coming back locally, particularly after partial penectomy where the surgical margins were close
- To the groin — when groin lymph nodes are involved or at high risk, radiation to the groin and pelvis reduces the chance of nodal recurrence after lymph node surgery
- Advanced or recurrent disease — radiation combined with chemotherapy provides local control for tumours that cannot be surgically removed
CION delivers radiation using IMRT — a precision technique that shapes the beam to the treatment target, reducing dose to surrounding healthy tissue. For penile cancer, IMRT minimises dose to the bowel, bladder, and femoral vessels during groin irradiation.
Every Case Reviewed by a Specialist Team
Penile cancer management requires surgical oncology, radiation oncology, and pathology working together. At CION, every penile cancer case is reviewed by our multidisciplinary tumour board before treatment begins:
- MRI penis reviewed to confirm tumour depth and organ-sparing feasibility
- Groin node status assessed — sentinel node biopsy vs full dissection decision
- Organ-sparing approach evaluated before any penectomy is recommended
- Reconstruction options discussed for patients requiring penectomy
- Chemotherapy planned for Stage III–IV disease
- Radiation to penis and/or groin planned with IMRT precision
- Psychological support pathway established from the time of diagnosis
- NCCN protocol adherence across the entire treatment plan
- Digital coordination across all 7 Hyderabad locations for uninterrupted care
Why Patients Choose CION for Penile Cancer Treatment in Hyderabad
Volume, surgical and radiation oncology expertise, organ-sparing-first philosophy, and complete confidentiality at every step.
15,000+ patients treated
7 locations across Hyderabad
NABH Accredited Cancer Care
Organ-sparing surgery first
Sentinel lymph node biopsy available
Dedicated Second Opinion service
EMI facility
4.8 / 5 Google rating
35+ centres across Telangana & AP
Did You Know?
Phimosis — a condition where the foreskin cannot be fully pulled back — is one of the most significant risk factors for penile cancer in India. Men with phimosis are unable to clean properly under the foreskin, which allows chronic inflammation and HPV infection to persist. If you have phimosis and are experiencing any changes in the skin under the foreskin — a persistent sore, unusual discharge, or thickening — do not wait. An early assessment is quick, straightforward, and dramatically improves outcomes.
Penile Cancer Treatment Cost in Hyderabad
Costs vary based on the stage of cancer and the surgical approach required. A personalised cost estimate is provided following your initial oncology consultation at CION.
| Treatment | Approx. Cost (INR) | Notes |
|---|---|---|
| Wide Local Excision / Laser Ablation (early stage) | ₹40,000 – ₹1,50,000 | Day procedure; local or spinal anaesthesia |
| Circumcision for foreskin-confined cancer | ₹30,000 – ₹80,000 | If cancer confined to foreskin only |
| Glansectomy with Skin Graft Reconstruction | ₹1,20,000 – ₹3,00,000 | Organ-sparing for glans involvement; 1–2 day stay |
| Partial Penectomy | ₹1,50,000 – ₹3,50,000 | For deeper invasion; 2–3 day stay |
| Total Penectomy + Urinary Diversion | ₹2,00,000 – ₹5,00,000 | For extensive disease; includes stoma care |
| Sentinel Lymph Node Biopsy | ₹60,000 – ₹1,50,000 | Minimally invasive; avoids full groin dissection |
| Inguinal Lymph Node Dissection (groin surgery) | ₹1,00,000 – ₹2,50,000 | For confirmed or high-risk node involvement |
| IMRT Radiation Therapy (full course) | ₹1,20,000 – ₹2,50,000 | For primary or adjuvant radiation |
| Chemotherapy (per cycle, advanced disease) | ₹25,000 – ₹75,000 | For Stage III–IV disease |
Financial Support Options
- EMI Facility — flexible instalment-based payment options available for all patients
- Private Health Insurance — CION works with all major TPAs for cashless hospitalisation
Penile Cancer Care Near You — In Hyderabad & Beyond
CION operates 35+ centres across Telangana and Andhra Pradesh. Find your nearest specialist or explore care options in your city. All consultations are handled with complete confidentiality.
Penile Cancer Care in Hyderabad — by Location
Penile Cancer Care Beyond Hyderabad
Travelling for treatment? We may have a centre right where you are — across Telangana and Andhra Pradesh.
Not seeing your city? Call 18002028726 — we'll connect you to the nearest CION centre or arrange a confidential teleconsultation.
Hear From Men Who've Walked This Journey
Patient experiences across our 7 Hyderabad centres, shared with consent.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Frequently Asked Questions
Common questions about penile cancer treatment in Hyderabad — answered by CION's surgical and radiation oncology team.
Is penile cancer curable?
What are the symptoms of penile cancer?
Can penile cancer be treated without removing the penis?
What causes penile cancer?
How is penile cancer diagnosed?
What is the survival rate for penile cancer?
What is a penectomy?
Is penile cancer related to HPV?
What is the cost of penile cancer treatment in Hyderabad?
Can I get a second opinion for penile cancer?
Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.